Hereditary persistence of fetal hemoglobin, beta thalassemia, and the hemoglobin delta-beta locus: further family data and genetic interpretations
- PMID:1124762
- PMCID: PMC1762752
Hereditary persistence of fetal hemoglobin, beta thalassemia, and the hemoglobin delta-beta locus: further family data and genetic interpretations
Abstract
Three Negro kindreds with hereditary persistence of fetal hemoglobin (HPFH) alone and in combination with various other hemoglobin abnormalities including beta thalassemia are presented. Among 11 offspring of two women heterozygous for both HPFH and the delta chain mutation Hb B2, five inherited the HPFH gene and six inherited the Hb B2 gene. In another kindred, a man inferred to be heterozygous for both HPFH and Hb C had six children; three offsprivg obtained the Hb C gene and three the HPFH gene. Similarly, a woman heterozygous for both Hb S and HPFH transmitted the Hb S gene to one of her two children and the HPFH gene to the other. Thus among 19 offspring, no crossovers between the HPFH locus or the Hb delta-beta locus were observed. These and earlier data are compatible with deletion of the Hb beta and delta loci as the primary event to explain the genetic origin of HPFH. Genetic considerations indicate that the finding of a single person with a hematologically normal phenotype among offspring of heterozygotes for both the African type of HPFH and a Hb beta or Hb delta structural abnormality would invalidate the deletion model.
Similar articles
- A G gamma type of the hereditary persistence of fetal hemoglobin with beta chain production in cis.Huisman TH, Miller A, Schroeder WA.Huisman TH, et al.Am J Hum Genet. 1975 Nov;27(6):765-77.Am J Hum Genet. 1975.PMID:1200028Free PMC article.
- Interaction of two different disorders in the beta-globin gene cluster associated with an increased hemoglobin F production: a novel deletion type of (G) gamma + ((A) gamma delta beta)(0)-thalassemia and a delta(0)-hereditary persistence of fetal hemoglobin determinant.Losekoot M, Fodde R, Gerritsen EJ, van de Kuit I, Schreuder A, Giordano PC, Vossen JM, Bernini LF.Losekoot M, et al.Blood. 1991 Feb 15;77(4):861-7.Blood. 1991.PMID:1704267
- Heterocellular hereditary persistence of fetal hemoglobin (HPFH). Molecular mechanisms of abnormal gamma-gene expression in association with beta thalassemia and linkage relationship with the beta-globin gene cluster.Giampaolo A, Mavilio F, Sposi NM, Carè A, Massa A, Cianetti L, Petrini M, Russo R, Cappellini MD, Marinucci M.Giampaolo A, et al.Hum Genet. 1984;66(2-3):151-6. doi: 10.1007/BF00286590.Hum Genet. 1984.PMID:6201431
- Delta beta thalassemia and hereditary persistence of fetal hemoglobin.Bollekens JA, Forget BG.Bollekens JA, et al.Hematol Oncol Clin North Am. 1991 Jun;5(3):399-422.Hematol Oncol Clin North Am. 1991.PMID:1713909Review.
- Interpreting elevated fetal hemoglobin in pathology and health at the basic laboratory level: new and known γ- gene mutations associated with hereditary persistence of fetal hemoglobin.Amato A, Cappabianca MP, Perri M, Zaghis I, Grisanti P, Ponzini D, Di Biagio P.Amato A, et al.Int J Lab Hematol. 2014 Feb;36(1):13-9. doi: 10.1111/ijlh.12094. Epub 2013 Apr 29.Int J Lab Hematol. 2014.PMID:23621512Review.
Cited by
- Clinical genetics: ghanaian gratitude for british and hungarian contributions: a personalized historical perspective.Konotey-Ahulu FI.Konotey-Ahulu FI.Ghana Med J. 2009 Dec;43(4):175-8.Ghana Med J. 2009.PMID:21326998Free PMC article.No abstract available.
- Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4+ and CD8+ T cells.Zurlo M, Nicoli F, Proietto D, Dallan B, Zuccato C, Cosenza LC, Gasparello J, Papi C, d'Aversa E, Borgatti M, Scapoli C, Finotti A, Gambari R.Zurlo M, et al.J Cell Mol Med. 2023 Feb;27(3):353-364. doi: 10.1111/jcmm.17655. Epub 2023 Jan 10.J Cell Mol Med. 2023.PMID:36625233Free PMC article.Clinical Trial.
- A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease.Howard J, Hemmaway CJ, Telfer P, Layton DM, Porter J, Awogbade M, Mant T, Gretler DD, Dufu K, Hutchaleelaha A, Patel M, Siu V, Dixon S, Landsman N, Tonda M, Lehrer-Graiwer J.Howard J, et al.Blood. 2019 Apr 25;133(17):1865-1875. doi: 10.1182/blood-2018-08-868893. Epub 2019 Jan 17.Blood. 2019.PMID:30655275Free PMC article.Clinical Trial.
- Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease.Cannon M, Phillips H, Smith S, Williams K, Brinton L, Gregory C, Landes K, Desai P, Byrd J, Lapalombella R.Cannon M, et al.J Clin Med. 2020 Jul 17;9(7):2276. doi: 10.3390/jcm9072276.J Clin Med. 2020.PMID:32708954Free PMC article.
References
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources